Acute hepatitis B incidence
rate/100,000. Data source: UKHSA surveillance Acute Hepatitis B
dataset, compiled from laboratory and Health Protection Team
reports
Adjusted antibiotic prescribing in
primary care by the NHS. Data source: Data is sourced from ePACT2
from NHS Digital
All new STI diagnoses rate per
100,000. Data source: UK Health Security Agency (UKHSA)
Campylobacter incidence
rate/100,000. Data source: UKHSA Second Generation Surveillance
System - SGSS - (Laboratory Surveillance)
Children in care
immunisations. Data source: Department for Education
(DfE)
Chlamydia detection rate per
100,000 aged 15 to 24. Data source: UK Health Security Agency
(UKHSA)
Chlamydia detection rate per
100,000 aged 15 to 24. Data source: UK Health Security Agency
(UKHSA)
Chlamydia diagnostic rate per
100,000. Data source: UK Health Security Agency (UKHSA)
Chlamydia diagnostic rate per
100,000 aged 25 years and older. Data source: UK Health Security
Agency (UKHSA)
Chlamydia proportion aged 15 to 24
screened. Data source: UK Health Security Agency (UKHSA)
Cryptosporidium incidence
rate/100,000. Data source: UKHSA Second Generation Surveillance
System - SGSS - (Laboratory Surveillance)
Fraction of mortality attributable
to particulate air pollution (new method). Data source:
Background annual average PM2.5 concentrations for the year of interest
are modelled on a 1km x 1km grid using an air dispersion model, and
calibrated using measured concentrations taken from background sites in
Defra’s Automatic Urban and Rural Network (https://uk-air.defra.gov.uk/interactive-map). By
approximating LA boundaries to the 1km by 1km grid, and using census
population data, population weighted background PM2.5 concentrations for
each lower tier LA are calculated. This work is completed under contract
to Defra, as a small extension of its obligations under the Ambient Air
Quality Directive (2008/50/EC). Concentrations of total PM2.5 are used
for estimating the mortality burden attributable to particulate air
pollution (COMEAP, 2022).
Fraction of mortality attributable
to particulate air pollution (old method). Data source:
Background annual average PM2.5 concentrations for the year of interest
are modelled on a 1km x 1km grid using an air dispersion model, and
calibrated using measured concentrations taken from background sites in
Defra’s Automatic Urban and Rural Network (http://uk-air.defra.gov.uk/interactive-map.) Data on
primary emissions from different sources and a combination of
measurement data for secondary inorganic aerosol and models for sources
not included in the emission inventory (including re-suspension of
dusts) are used to estimate the anthropogenic (human-made) component of
these concentrations. By approximating LA boundaries to the 1km by 1km
grid, and using census population data, population weighted background
PM2.5 concentrations for each lower tier LA are calculated. This work is
completed under contract to Defra, as a small extension of its
obligations under the Ambient Air Quality Directive (2008/50/EC).
Concentrations of anthropogenic, rather than total, PM2.5 are used as
the basis for this indicator, as burden estimates based on total PM2.5
might give a misleading impression of the scale of the potential
influence of policy interventions (COMEAP, 2012).
Genital herpes diagnosis rate per
100,000. Data source: UK Health Security Agency (UKHSA)
Genital warts diagnostic rate per
100,000. Data source: UK Health Security Agency (UKHSA)
Giardia incidence
rate/100,000. Data source: UKHSA Second Generation Surveillance
System - SGSS - (Laboratory Surveillance)
Gonorrhoea diagnostic rate per
100,000. Data source: UK Health Security Agency (UKHSA)
HIV diagnosed prevalence rate per
1,000 aged 15 to 59. Data source: UK Health Security Agency
(UKHSA)
HIV late diagnosis in gay, bisexual
and other men who have sex with men first diagnosed with HIV in the
UK. Data source: UK Health Security Agency (UKHSA)
HIV late diagnosis in heterosexual
and bisexual women first diagnosed with HIV in the UK. Data
source: UK Health Security Agency (UKHSA)
HIV late diagnosis in heterosexual
men first diagnosed with HIV in the UK. Data source: UK Health
Security Agency (UKHSA)
HIV late diagnosis in people first
diagnosed with HIV in the UK. Data source: UK Health Security
Agency (UKHSA)
HIV testing coverage, gay, bisexual
and other men who have sex with men. Data source: UK Health
Security Agency (UKHSA)
HIV testing coverage, men.
Data source: UK Health Security Agency (UKHSA)
HIV testing coverage, total.
Data source: UK Health Security Agency (UKHSA)
HIV testing coverage, women.
Data source: UK Health Security Agency (UKHSA)
Hepatitis C detection
rate/100,000. Data source: SGSS data (Second Generation
Surveillance System) - Laboratory reporting. UKHSA
Invasive Meningococcal Disease
(IMD) confirmed cases rate/100,000. Data source: UKHSA
Meningococcal Reference Unit (MRU)
Legionnaires’ disease confirmed
incidence rate/100,000. Data source: National Enhanced
Surveillance Scheme for Legionnaires’ disease in residents of England,
UKHSA
Listeria 5-year incidence
rate/100,000. Data source: National Enhanced Surveillance Scheme
for Listeria for residents of England and Wales, UKHSA
Listeria incidence
rate/100,000. Data source: National Enhanced Surveillance Scheme
for Listeria for residents of England and Wales, UKHSA
Measles 5-year incidence
rate/100,000. Data source: UKHSA Measles Enhanced Surveillance
Programme.
Measles incidence
rate/100,000. Data source: UKHSA Measles Enhanced Surveillance
Programme.
Mumps 5-year incidence
rate/100,000. Data source: UKHSA Mumps Enhanced Surveillance
Programme
Mumps incidence
rate/100,000. Data source: UKHSA Mumps Enhanced Surveillance
Programme
Mycoplasma genitalium diagnostic
rate per 100,000. Data source: UK Health Security Agency
(UKHSA)
New HIV diagnoses among persons
first diagnosed in the UK rate per 100,000. Data source: UK
Health Security Agency (UKHSA)
New HIV diagnosis rate per
100,000. Data source: UK Health Security Agency (UKHSA)
New STI diagnoses (excluding
chlamydia aged under 25) per 100,000. Data source: UK Health
Security Agency (UKHSA)
Non-typhoidal Salmonella incidence
rate/100,000. Data source: UKHSA Second Generation Surveillance
System - SGSS - (Laboratory Surveillance)
Persons entering drug misuse
treatment - Percentage of eligible persons completing a course of
hepatitis B vaccination. Data source: Public Health England,
National Drug Treatment Monitoring System (NDTMS)
Persons in drug misuse treatment
who inject drugs - Percentage of eligible persons who have received a
hepatitis C test. Data source: Public Health England, (based on
National Drug Treatment Monitoring System data)
Pertussis incidence
rate/100,000. Data source: UKHSA pertussis enhanced surveillance
programme
Population vaccination coverage -
Hib / Men C booster (5 years old). Data source: Cover of
Vaccination Evaluated Rapidly (COVER) data collected by Public Health
England (PHE). Available from NHS Digital
Population vaccination coverage -
Shingles vaccination coverage (70 years old). Data source: Public
Health England
Population vaccination coverage
BCG: areas offering universal BCG only. Data source: Cover of
Vaccination Evaluated Rapidly (COVER) data collected by UK Health
Security Agency (UKHSA)
Population vaccination coverage:
Rotavirus (Rota) (1 year). Data source: NHS Digital
Population vaccination coverage:
Dtap IPV Hib (2 years old). Data source: Cover of Vaccination
Evaluated Rapidly (COVER) data collected by UK Health Security Agency
(UKHSA|). Available from NHS Digital
Population vaccination coverage:
Dtap IPV Hib (1 year old). Data source: Cover of Vaccination
Evaluated Rapidly (COVER) data collected by UK Health Security Agency
(UKHSA). Available from NHS Digital
Population vaccination coverage:
Flu (aged 65 and over). Data source: https://www.gov.uk/government/collections/vaccine-uptake#seasonal-flu-vaccine-uptake:-figures
Population vaccination coverage:
Flu (at risk individuals). Data source: https://www.gov.uk/government/collections/vaccine-uptake#seasonal-flu-vaccine-uptake:-figures
Population vaccination coverage:
Flu (primary school aged children). Data source: https://www.gov.uk/government/collections/vaccine-uptake#seasonal-flu-vaccine-uptake:-figures
Influenza Immunisation Vaccine Uptake Monitoring Programme
Population vaccination coverage:
HPV vaccination coverage for two doses (13 to 14 years old). Data
source: UK Health Security Agency (UKHSA)
Population vaccination coverage:
Hepatitis B (1 year old). Data source: Cover of vaccination
evaluated rapidly (COVER) data collected by UK Health Security Agency
(UKHSA). Available from NHS Digital (former Health and Social Care
Information Centre) and UKHSA.
Population vaccination coverage:
Hepatitis B (2 years old). Data source: Cover of vaccination
evaluated rapidly (COVER) data collected by UK Health Security Agency
(UKHSA). Available from NHS Digital (former Health and Social Care
Information Centre)
Population vaccination coverage:
Hib and MenC booster (2 years old). Data source: Cover of
Vaccination Evaluated Rapidly (COVER) data collected by UK Health
Security Agency (UKHSA). Available from NHS Digital
Population vaccination coverage:
MMR for one dose (2 years old). Data source: Cover of Vaccination
Evaluated Rapidly (COVER) data collected by UK Health Security Agency
(UKHSA). Available from NHS Digital
Population vaccination coverage:
MMR for one dose (5 years old). Data source: Cover of Vaccination
Evaluated Rapidly (COVER) data collected by UK Health Security Agency
(UKHSA). Available from NHS Digital
Population vaccination coverage:
MMR for two doses (5 years old). Data source: Cover of
Vaccination Evaluated Rapidly (COVER) data collected by UK Health
Security Agency (UKHSA). Available from NHS Digital ”
Population vaccination coverage:
Meningococcal ACWY conjugate vaccine (MenACWY) (14 to 15 years).
Data source: UK Health Security Agency (UKHSA)
Population vaccination coverage:
PCV booster. Data source: Cover of Vaccination Evaluated Rapidly
(COVER) data collected by UK Health Security Agency (UKHSA). Available
from NHS Digital
Population vaccination coverage:
PPV. Data source: UK Health Security Agency (UKHSA)
Population vaccination coverage:
Shingles vaccination coverage (71 years). Data source: UK Health
Security Agency (UKHSA)
Prompt antiretroviral therapy (ART)
initiation in people newly diagnosed with HIV. Data source: UK
Health Security Agency (UKHSA)
Proportion of TB notifications
offered an HIV test. Data source: National Tuberculosis
Surveillance System (NTBS). UK Health Security Agency (UKHSA).
Proportion of culture confirmed TB
notifications with drug susceptibility testing reported for the four
first line agents. Data source: National Tuberculosis
Surveillance system (NTBS). UK Health Security Agency (UKHSA).
Proportion of drug sensitive TB
cases who were lost to follow up at last reported outcome. Data
source: National Tuberculosis System (NTBS) and Office for National
Statistics (ONS)
Proportion of drug sensitive TB
notifications who had completed a full course of treatment by 12
months. Data source: National Tuberculosis Surveillance System
(NTBS)
Proportion of drug sensitive TB
notifications who had died at last reported outcome. Data source:
National Tuberculosis Surveillance system (NTBS)
Proportion of pulmonary TB
notifications starting treatment within four months of symptom
onset. Data source: National Tuberculosis Surveillance system
(NTBS). UK Health Security Agency (UKHSA).
Proportion of pulmonary TB
notifications starting treatment within two months of symptom
onset. Data source: National Tuberculosis Surveillance system
(NTBS). UK Health Security Agency (UKHSA).
Proportion of pulmonary TB
notifications that were culture confirmed. Data source: National
Tuberculosis Surveillance system (NTBS). UK Health Security Agency
(UKHSA).
Repeat HIV testing in gay, bisexual
and other men who have sex with men. Data source: UK Health
Security Agency (UKHSA)
STEC (Shiga toxin-producing
Escherichia coli) serogroup O157 5-year incidence rate/100,000.
Data source: National Enhanced Shiga toxin producing Escherichia coli
Surveillance System (NESSSy) for residents of England, UKHSA
STEC (Shiga toxin-producing
Escherichia coli) serogroup O157 incidence rate/100,000. Data
source: National Enhanced Shiga toxin-producing Escherichia coli
Surveillance System (NESSSy) for residents of England, UKHSA
STI testing positivity (excluding
chlamydia aged under 25). Data source: UK Health Security Agency
(UKHSA)
STI testing rate (exclude chlamydia
aged under 25) per 100,000. Data source: UK Health Security
Agency (UKHSA)
Scarlet fever notification
rate/100,000 aged 0-9 yrs. Data source: NOIDS (Notifications of
Infectious Disease Surveillance) https://www.gov.uk/government/collections/notifications-of-infectious-diseases-noids
Shigella incidence
rate/100,000. Data source: UKHSA national Second Generation
Surveillance System (SGSS) for laboratory surveillance of infectious
disease
Syphilis diagnostic rate per
100,000. Data source: UK Health Security Agency (UKHSA)
TB incidence (three year
average). Data source: National Tuberculosis Surveillance System
(NTBS) and Office for National Statistics (ONS)
Trichomoniasis diagnostic rate per
100,000. Data source: UK Health Security Agency (UKHSA)
Typhoid & paratyphoid incidence
rate/100,000. Data source: National Enhanced Surveillance Scheme
for Typhoid and Paratyphoid in residents of England, UKHSA
Under 75 mortality rate from
hepatitis B related end-stage liver disease/hepatocellular
carcinoma. Data source: Office for Health Improvement and
Disparities (OHID) (based on ONS source data)
Under 75 mortality rate from
hepatitis C related end-stage liver disease/hepatocellular
carcinoma. Data source: Office for Health Improvement and
Disparities (OHID) (based on ONS source data)
Virological success in adults
accessing HIV care. Data source: UK Health Security Agency
(UKHSA)